SCHEMBL30192164

SCHEMBL30192164

NC(=O)C[C@H](NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O

nearest known ligand 0.36

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 9/20 0.36
▸ ECE1 P42892 3/20 0.34
▸ MME P08473 1/20 0.34
▸ ITGB2 P05107 1/20 0.33
▸ ICAM1 P05362 1/20 0.33
▸ ITGAL P20701 1/20 0.33
▸ CTSD P07339 1/20 0.33
▸ CA2 P00918 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29630501 0.96 BACE1 (0.34) BACE1ECE1MME
SCHEMBL29373629 0.94 ECE1 (0.39) BACE1ECE1MMEITGB2ICAM1
SCHEMBL31707374 0.93 MME (0.38) BACE1ECE1MMEITGB2ICAM1
SCHEMBL31073533 0.93 PDCD1LG2 (0.39) BACE1ECE1MMEITGB2ICAM1
SCHEMBL29510840 0.92 MME (0.38) BACE1MMECTSD
SCHEMBL31474495 0.92 BACE1 (0.33) BACE1ECE1MME
SCHEMBL29383357 0.92 ECE1 (0.34) ECE1MME
SCHEMBL30822978 0.92 SLC15A2 (0.35) MME
SCHEMBL10856404 0.92 SLC15A2 (0.35) MME
SCHEMBL30712894 0.92 SLC15A2 (0.35) MME

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026090356-A2 MODIFIED MAMMALIAN CELLS FOR IMPROVED PRODUCTION GENZYME CORPORATION (US) 2026-04-30 — — WO disclosed
US-20250295796-A1 CELL PENETRATING POLYPEPTIDES (CPPS) AND THEIR USE IN HUMAN THERAPY PAGS CO., LTD. (KR) 2025-09-25 — — US disclosed
EP-4514972-A1 PROTECTING OLIGONUCLEOTIDES FOR CRISPR GUIDE RNA University Of Massachusetts (US) 2025-03-05 — — EP disclosed
CN-119563023-A Protective oligonucleotides for CRISPR guide RNA 马萨诸塞大学 2025-03-04 — — CN disclosed
US-20240352499-A1 POLYNUCLEOTIDES ENCODING NOVEL NUCLEASES, COMPOSITIONS THEREOF AND METHODS THEREOF FOR ELIMINATING DNA FROM PROTEIN PREPARATIONS DANISCO US INC (US) 2024-10-24 — — US disclosed
EP-4448556-A1 CELL PENETRATING POLYPEPTIDES (CPPS) AND THEIR USE IN HUMAN THERAPY RDP Pharma AG (CH) 2024-10-23 — — EP disclosed
CN-118786136-A Cell Penetrating Polypeptide (CPP) and its use in human therapy RDP制药股份公司 2024-10-15 — — CN disclosed
EP-4388077-A1 POLYNUCLEOTIDES ENCODING NOVEL NUCLEASES, COMPOSITIONS THEREOF AND METHODS THEREOF FOR ELIMINATING DNA FROM PROTEIN PREPARATIONS Danisco US Inc. (US) 2024-06-26 — — EP disclosed
CN-118240856-A Escherichia coli toxic protein and application and prokaryotic expression method thereof 中国人民解放军陆军军医大学第二附属医院 2024-06-25 — — CN disclosed
CN-117881772-A Polynucleotides encoding novel nucleases, compositions thereof and methods for eliminating DNA from protein preparations 丹尼斯科美国公司 2024-04-12 — — CN disclosed
US-20240043877-A1 COMPOSITIONS AND METHODS FOR GENETIC MANIPULATION OF METHANOTROPHS AQUA-SPARK CALYSTA LLC (NL) 2024-02-08 — — US disclosed
US-20230407295-A1 PROTECTING OLIGONUCLEOTIDES FOR CRISPR GUIDE RNA UNIV MASSACHUSETTS (US) 2023-12-21 — — US disclosed
WO-2023212327-A1 PROTECTING OLIGONUCLEOTIDES FOR CRISPR GUIDE RNA UNIVERSITY OF MASSACHUSETTS (US) 2023-11-02 — — WO disclosed
WO-2023111213-A1 CELL PENETRATING POLYPEPTIDES (CPPS) AND THEIR USE IN HUMAN THERAPY RDP PHARMA AG (CH) 2023-06-22 — — WO disclosed
CN-115956120-A Modified guide RNAs for CRISPR genome editing 马萨诸塞大学 2023-04-11 — — CN disclosed
EP-4150091-A2 MODIFIED GUIDE RNAS FOR CRISPR GENOME EDITING University Of Massachusetts (US) 2023-03-22 — — EP disclosed
WO-2023023644-A1 POLYNUCLEOTIDES ENCODING NOVEL NUCLEASES, COMPOSITIONS THEREOF AND METHODS THEREOF FOR ELIMINATING DNA FROM PROTEIN PREPARATIONS DANISCO US INC. (US) 2023-02-23 — — WO disclosed
US-20220356484-A1 GENETIC MODIFICATION OF PLANTS TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2022-11-10 — — US disclosed
Send feedback